Curiox Biosystems Co., Ltd (KOSDAQ:445680)

Curiox Biosystems Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	10,058	14,785	24,188	17,909	5,597	11,003
Short-Term Investments	6,605	3,000	4,000	-	3,125	8,816
Cash & Short-Term Investments	16,664	17,785	28,188	17,909	8,722	19,819
Cash Growth	-34.20%	-36.90%	57.39%	105.34%	-55.99%	152.38%
Accounts Receivable	1,189	1,845	557.32	1,723	1,832	1,240
Other Receivables	252.76	234.26	132.13	98.19	68.97	86.29
Receivables	1,442	2,079	689.45	1,821	1,901	1,326
Inventory	1,678	1,685	1,791	1,621	2,911	1,759
Prepaid Expenses	379.23	403.31	356.57	173.81	79.92	23.37
Other Current Assets	18,264	18,202	1,242	75.54	336.57	132.05
Total Current Assets	38,427	40,155	32,267	21,601	13,949	23,060
Property, Plant & Equipment	1,755	1,762	2,095	2,391	998.06	543.1
Long-Term Investments	-	-	-	-	-	0
Goodwill	28,238	26,937	26,059	23,547	22,733	21,143
Other Intangible Assets	9,119	9,011	9,922	10,056	10,761	10,969
Other Long-Term Assets	186.34	163.47	217.71	203.37	185.77	78.5
Total Assets	77,726	78,027	70,561	57,798	48,627	55,793

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	223.33	96.95	190.32	330	929.48	937.19
Accrued Expenses	457.49	457.78	595.99	375.03	537.34	441.11
Short-Term Debt	1,943	1,841	7,398	-	-	30,148
Current Portion of Leases	360.96	299.52	423.79	358.97	219.12	56.96
Current Unearned Revenue	683.14	670.31	585.74	669.72	539.41	286.02
Other Current Liabilities	20,537	20,012	10,723	982.85	609.44	411.63
Total Current Liabilities	24,205	23,377	19,918	2,717	2,835	32,281
Long-Term Leases	253.34	309.46	319.98	606.19	168.09	241.58
Long-Term Deferred Tax Liabilities	1,550	1,531	1,685	1,592	1,764	1,564
Other Long-Term Liabilities	-	0	0	-	0	0
Total Liabilities	26,008	25,218	21,923	4,915	4,767	34,087

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	8,560	8,560	8,062	4,011	3,284	543
Additional Paid-In Capital	114,644	114,644	85,421	88,965	71,651	27,944
Retained Earnings	-83,373	-80,732	-53,556	-45,466	-35,426	-23,931
Comprehensive Income & Other	11,883	10,334	8,705	5,369	4,344	1,027
Total Common Equity	51,714	52,805	48,632	52,879	43,853	5,582
Minority Interest	4.48	4.41	5.06	4.93	7.82	10.82
Shareholders' Equity	51,718	52,810	48,637	52,883	43,861	21,707
Total Liabilities & Equity	77,726	78,027	70,561	57,798	48,627	55,793

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	2,557	2,450	8,142	965.16	387.21	30,446
Net Cash (Debt)	14,107	15,335	20,045	16,944	8,334	-10,627
Net Cash Growth	-16.43%	-23.50%	18.30%	103.30%	-	-
Net Cash Per Share	841.60	928.33	1246.49	1185.37	1174.42	-815.46
Filing Date Shares Outstanding	17.12	17.12	16.12	16.04	13.14	13.03
Total Common Shares Outstanding	17.12	17.12	16.12	16.04	13.14	13.03
Working Capital	14,222	16,777	12,349	18,884	11,115	-9,221
Book Value Per Share	3020.69	3084.44	3016.12	3295.64	3337.89	428.32
Tangible Book Value	14,356	16,857	12,651	19,276	10,359	-26,530
Tangible Book Value Per Share	838.58	984.67	784.63	1201.37	788.46	-2035.79
Machinery	3,107	2,935	2,837	2,440	1,219	740.14
Construction In Progress	-	-	102.38	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 9, 2026

Data Sources Report a data error